Laurel Mercy Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 Cedar Ave, Laurel, NE 68745 Phone: 402-256-3042 Fax: 402-256-3043 |
News Archive
Overwhelming evidence accumulated during almost 20 years of clinical experience has established the benefits of this drug, which blocks the harmful effects of angiotensin, a substance that causes blood vessels to narrow, said the study authors.
George Tsokos, MD, Chief of Rheumatology at Beth Israel Deaconess Medical Center and a national leader in the field of lupus research was honored by both the Lupus Foundation of America and the American College of Rheumatology with two prestigious awards presented during the 2014 ACR Annual Scientific Meeting recently held in Boston.
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
This week Global Health Action has published "A Declaration on Mental Health in Africa: moving to implementation". The 25 original signatories, all leaders within global and mental health from Africa and other nations, call upon citizens and the mental health care community to add their names to an online petition to show support for the actions outlined.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
› Verified 2 days ago